U.S. Court of Appeals for the Federal Circuit
Indivior Inc. v. Dr. Reddy's Laboratories, S.A.
This writing
- Type
- Dissent
- Filed
- July 12, 2019
- Case
- Indivior Inc. v. Dr. Reddy's Laboratories, S.A.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Mayer, Circuit Judge, dissenting. There is no need for this court to reach the issue of infringement because the three patents- U.S. Patent Nos. 8,017,150 B2 (the " '150 patent"), 8,603,514 B2 (the " '514 patent"), and 8,900,497 B2 (the " '497 patent")-asserted by Indivior Inc., Indivior UK Limited, and Aquestive Therapeutics, Inc. (collectively, "Indivior") are invalid as obvious. I therefore respectfully dissent.…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.
Other writings in this case
| Type | Author | Filed |
|---|---|---|
| Opinion | Not attributed | July 12, 2019 |
| Opinion of the Court | Not attributed | July 12, 2019 |